TELA News and Press, TELA Bio Inc. From 07/21/21

MALVERN, Pa., July 21, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced today the fi...

MALVERN, Pa., June 14, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Com...

MALVERN, Pa., May 25, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced the appointment of ...

MALVERN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Comp...

TELA Bio (TELA) launches a post-market study, BRAVO II, to evaluate the clinical performance of OviTex Reinforced Tissue Matrices in the robotic repair of ventral hernias.The company expects to enroll up to 100 subjects in the study at up to seven US-based sites, with patient follow-up at 90 ...

MALVERN, Pa., May 19, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today launched the company's ...

TELA Bio Inc. (TELA) Q1 2021 Earnings Conference Call May 13, 2021 04:30 PM ET Company Participants Hannah Jeffrey - Gilmartin Group Tony Koblish - President and CEO Nora Brennan - CFO Conference Call Participants Anthony Petrone - Jefferies Dave Turkaly - JMP Securities Kyle Rose - Canaccord...

Image source: The Motley Fool. TELA Bio, Inc. (NASDAQ: TELA) Q1 2021 Earnings Call May 13, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: TELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript

TELA Bio (TELA): Q1 GAAP EPS of -$0.56 misses by $0.04.Revenue of $5.9M (+58.2% Y/Y) beats by $0.44M.Cash and Cash Equivalents at March 31, 2021 of $65.8M.For the full year 2021, TELA Bio is maintaining the total revenue guidance to be in the range of $27.0 million to $30.0 million, represent...

MALVERN, Pa., May 13, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported...